Yuyu Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Yuyu Pharma has a total shareholder equity of ₩131.3B and total debt of ₩34.7B, which brings its debt-to-equity ratio to 26.4%. Its total assets and total liabilities are ₩200.8B and ₩69.6B respectively. Yuyu Pharma's EBIT is ₩12.6B making its interest coverage ratio 8.2. It has cash and short-term investments of ₩43.9B.
Key information
26.4%
Debt to equity ratio
₩34.68b
Debt
| Interest coverage ratio | 8.2x |
| Cash | ₩43.88b |
| Equity | ₩131.25b |
| Total liabilities | ₩69.55b |
| Total assets | ₩200.80b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A000225's short term assets (₩106.1B) exceed its short term liabilities (₩62.3B).
Long Term Liabilities: A000225's short term assets (₩106.1B) exceed its long term liabilities (₩7.2B).
Debt to Equity History and Analysis
Debt Level: A000225 has more cash than its total debt.
Reducing Debt: A000225's debt to equity ratio has increased from 26.2% to 26.4% over the past 5 years.
Debt Coverage: A000225's debt is well covered by operating cash flow (82.9%).
Interest Coverage: A000225's interest payments on its debt are well covered by EBIT (8.2x coverage).